(Q44493549)
Statements
1 reference
Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease (English)
1 reference
Philippe Rousselot
1 reference
Aude Charbonnier
1 reference
Pascale Cony-Makhoul
1 reference
Philippe Agape
1 reference
Franck E Nicolini
1 reference
Bruno Varet
1 reference
Martine Gardembas
1 reference
Gabriel Etienne
1 reference
Lydia Roy
1 reference
Martine Escoffre-Barbe
1 reference
Agnès Guerci-Bresler
1 reference
Michel Tulliez
1 reference
Marc Spentchian
1 reference
Jean Michel Cayuela
1 reference
Josy Reiffers
1 reference
Jean Claude Chomel
1 reference
Joëlle Guilhot
1 reference
François-Xavier Mahon
1 reference
9 December 2013
1 reference
1 reference
32
1 reference
5
1 reference
424-430
1 reference
Identifiers
1 reference
1 reference